In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Patricia Eifel from MD Anderson Cancer Center to talk about updates on radiotherapy for vulvar cancer.
In this episode of the IJGC podcast, Editor-in-Chief, Dr. Pedro Ramirez, is joined by Dr. Anuja Jhingran from MD Anderson Cancer Center to talk about updates on radiotherapy management of cervical cancer.
In this episode of the IJGC podcast, Editor-in-Chief, Dr. Pedro Ramirez, is joined by Dr. Christhardt Köhler from Asklepios Clinic Hamburg-Altona to talk about his article “Laparoscopic radical hysterectomy with transvaginal closure of vaginal cuff – a multicenter analysis," which is the Lead Article for the June issue.
In this episode of the IJGC podcast, Editor-in-Chief, Dr. Pedro Ramirez, is joined by Dr. Andrea Mariani from the Mayo Clinic, to talk about clinical implications of sentinel lymph node mapping in endometrial cancer.
In this episode of the IJGC podcast, Editor-in-Chief, Dr. Pedro Ramirez, is joined by Dr. Gabriel Mena (Twitter: @GabeMenaMD) from MD Anderson Cancer Center in Houston, Texas, to talk about goal-directed fluid therapy and multi-modal analgesia in ERAS anesthesia. They discuss the role of anesthesiologists and the integration of anesthesia in the success of an enhanced recovery program.
In this episode of the IJGC podcast, Editor-in-Chief, Dr. Pedro Ramirez, is joined by Dr. Alessandro Buda (Twitter: @alicchio72) from San Gerardo Hospital, University of Milano Bicocca, in Monza, Italy, to talk about the role of neoadjuvant chemotherapy in early-stage cervical cancer. They discuss fertility sparing, current literature on the subject, and response rates.
Dr. Pedro Ramirez, MD Anderson Cancer Center; Dr. Gregg Nelson, The University of Calgary's Cumming School of Medicine Small description of your podcast: In this episode of the IJGC podcast, Editor-in-Chief, Dr. Pedro Ramirez, is joined by Dr. Gregg Nelson (Twitter: @GreggNelsonERAS) from The University of Calgary's Cumming School of Medicine, to talk about the 2019 update to the Enhanced Recovery After Surgery (ERAS) Society Guidelines for perioperative care in gynecologic oncology. The full ar...
In this episode of the IJGC podcast, Editor-in-Chief, Dr. Pedro Ramirez, is joined by Dr. Kathleen Schmeler (Twitter: @kmschmeler) from MD Anderson Cancer Center in Houston, Texas, to talk about the efforts in global prevention and care of women with gynecologic cancer. They discuss barriers such as access to care, low cost screening, and shortage of providers, as well as educational guidelines and telementoring programs such as Project Echo.
In this episode of the IJGC podcast, Editor-in-Chief, Dr. Pedro Ramirez, is joined by Dr. Larissa Meyer (Twitter: @LarissaAMeyerMD) from MD Anderson Cancer Center in Houston, Texas, to talk about the role of patient reported outcomes (PROs) in gynecologic oncology. They discuss outcome measures and how to implement patient responses into your practice to improve care.
In this episode of the IJGC podcast, Editor-in-Chief, Dr. Pedro Ramirez, is joined by Dr. Anna Fagotti (Twitter: @annafagottimd) from Policlinico Universitario Agostino Gemelli in Rome to talk about the current role of laparoscopy in the assessment of tumor cytoreduction. They discuss imaging, the use of primary debulking surgery, multi-surgeon assessments, and current and future research on scoring.
In this episode of the IJGC podcast, Editor-in-Chief,Dr. Pedro Ramirez, is joined by Dr. Ane Gerda Eriksson from the Norwegian Radium Hospital, to talk about the role of sentinel lymph node mapping in endometrial cancer. They discuss the SLN mapping algorithm, detection in low-risk and high-risk patients, appropriate tracers, and pathological evaluation.
In this episode of the IJGC podcast, Editor-in-Chief, Dr. Pedro Ramirez, is joined by Dr. Robert Soslow from Memorial Sloan Kettering Cancer Center to talk about the three-tier classification of cervical carcinoma. The discuss the patterns A, B, and C in the Silva classification scheme and the clinical implications and reproducibility of these patterns. Check out Dr. Soslow's previous podcast for further information: https://soundcloud.com/bmjpodcasts/the-importance-and-clinical-relevance-of-cla...
In this episode of the IJGC podcast, Editor-in-Chief, Dr. Pedro Ramirez, is joined by Dr. David Gershenson (Twitter: @RareOvarCancers) from MD Anderson Cancer Center in Houston, Texas, to talk about updates on management of low-grade ovarian tumors. They discuss the grading classifications, the history and survival of low-grade and high-grade serous carcinoma, and determining the ideal patients for surgery or other types of treatment.
In this episode of the IJGC podcast, Editor-in-Chief, Dr. Pedro Ramirez, is joined by Dr. Raimundo Correa (@racobul) from Clinica Las Condes in Chile, to talk about palliative care in the management of patients with gynecological cancer. They discuss the use of the term "supportive care," the integration of palliative care with cancer treatment and the importance of a multidisciplinary team - including volunteers and family members - comprehensively looking after a patient's physical, emotional,...
In this episode of the IJGC podcast, Editor-in-Chief, Dr. Pedro Ramirez, is joined by Dr. Shannon Westin from MD Anderson Cancer Center in Houston, Texas, to talk about conservative management of endometrial cancer. They discuss the ideal candidates of conservative management, available imaging studies, discussing treatment options and side effects with patients, as well as response rates and recurrence.
In this episode of the IJGC podcast, Editor-in-Chief, Dr. Pedro Ramirez, is joined by Dr. Patrice Mathevet from the University of Lausanne in Switzerland. Dr. Mathevet is the author of the Lead Article for the March 2019 issue, "Impact of micrometastasis or isolated tumor cells on recurrence and survival in patients with early cervical cancer: SENTICOL Trial." They discuss the aim and results of the study, as well as the implications for future treatment.
In this episode of the IJGC podcast, Editor-in-Chief, Dr. Pedro Ramirez, is joined by Dr. Olle Ljungqvist (Twitter: @OlleLjungqvist) from the Örebro and Karolinska Institute to talk about implementation of enhanced recovery after surgery (ERAS) programs in gynecologic oncology. They discuss the ERAS guidelines and the implementation and outcomes of ERAS to enhance the patient's journey through recovery.
In this episode of the IJGC podcast, Editor-in-Chief, Dr. Pedro Ramirez, is joined by Dr. Robert Coleman (Twitter: @rcoledude) from MD Anderson Cancer Center in Houston, Texas, to talk about the role of secondary cytoreductive surgery in recurrent ovarian cancer. They discuss the importance, findings, and implications of surgical clinical trials such as GOG 213 and future studies on recurrent ovarian cancer.
In this episode of the IJGC podcast, Editor-in-Chief, Dr. Pedro Ramirez, is joined by Dr. Michael Frumovitz (Twitter: @Frumovitz) from MD Anderson Cancer Center in Houston, Texas, to talk about the role of sentinel lymph node mapping in cervical cancer. They discuss the uses of ICG and blue dye and other tracers in lymphatic mapping, the details of injection techniques, and how to use these approaches in your practice.
In this episode of the IJGC podcast, Editor-in-Chief, Dr. Pedro Ramirez, is joined by Dr. Juan Luis Alcázar (Twitter: @Juan_L_Alcazar) from the Department of Obstetrics and Gynecology, Clínica Universidad de Navarra in Pamplona, Spain. Dr. Alcázar is the lead author of the Lead Article for the February 2019 issue, "Preoperative assessment of intra-abdominal disease spread in epithelial ovarian cancer: a comparative study between ultrasound and computed tomography scan." They discuss the rational...
In this episode of the IJGC podcast, Editor-in-Chief, Dr. Pedro Ramirez, is joined by Dr. Robert Soslow from Memorial Sloan Kettering Cancer Center to talk about the importance and clinical relevance of a classification in patients with cervical cancer, particularly cervical adenocarcinoma. They discuss the way that cervical adenocarcinoma has been classified historically, the potential impact of a new classification scheme on clinical outcomes, and integrating testing in low resource areas. Loo...
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. David Gershenson (Twitter: @RareOvarCancers) from MD Anderson Cancer Center in Houston, Texas to talk about the management of rare ovarian tumors in ovarian cancers, including mucinous, clear cell, and small cell. They discuss metastatic vs. primary mucinous tumors, the role of HIPEC in the treatment of advanced disease, as well as genomic profiling. Look out for IJGC's upcoming pdocast with Dr. Gershenson on...
In this episode of the IJGC podcast, Editor-in-Chief, Dr. Pedro Ramirez, is joined by Dr. Robert Coleman (Twitter: @rcoledude) from MD Anderson Cancer Center in Houston, Texas. They discuss how parp inhibitors work and how they have come into play with gynecologic oncology, including how to discuss parp inhibitors with patients, recommendations for patient monitoring and follow up, and the future of ovarian cancer treatment.
In this episode of the IJGC podcast, Editor-in-Chief, Dr. Pedro Ramirez, is joined by Dr. Anna Fagotti (Twitter: @annafagottimd) from Policlinico Universitario Agostino Gemelli in Rome. Dr. Fagotti is the lead author of the Lead Article for the February 2018 issue, "The INTERNATIONAL MISSION study: Minimally Invasive Surgery In Ovarian Neoplasms after NACT." They discuss the origins and results of the study, what makes a patient an ideal candidate for minimally invasive surgery, and the next ste...
